<DOC>
	<DOCNO>NCT01276249</DOCNO>
	<brief_summary>The Aptus Endosystems STAPLE International Post-Market Registry intend expand clinical knowledge base include 'real world ' subject .</brief_summary>
	<brief_title>The STAPLE International Post-Market Registry</brief_title>
	<detailed_description>The Aptus Endosystems STAPLE International Post-Market Registry intend expand clinical knowledge base include 'real world ' subject . All subject diagnose qualify AAA suitable elective endovascular repair , meet inclusion/exclusion criterion registry , eligible enrollment offer informed consent participate .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Iliac Aneurysm</mesh_term>
	<criteria>1 . Patient ≥ 18 year old 2 . Patient give write informed consent 3 . Patient life expectancy &gt; 1 year 4 . Patient willing comply followup evaluation 5 . Patient 's AAA meet least one follow criterion : ≥ 4.5cm diameter Increased size 0.5cm last 6 month Maximum diameter exceed 1.5 time transverse dimension adjacent normal aortic segment Saccular aneurysm large 3cm maximal diameter 6 . Patient proximal aortic neck diameter measure inner wall inner wall 19mm 29mm 7 . Patient proximal aortic neck length least 12mm 8 . Patient patent iliac femoral artery allow endovascular access aneurysmal site 16Fr ( 5.3mm ) 18Fr ( 6.0mm ) delivery system . 9 . Patient bilateral iliac artery distal fixation site ≥ 10mm length internal diameter 9mm 20mm 1 . Patient participate concurrent clinical study may confound STAPLEInternational Registry result 2 . Patient symptomatic AAA 3 . Patient 's AAA proximal aortic neck angle &gt; 60 degree infrarenal neck long axis aneurysm 4 . Patient irregularlyshaped plaque would inhibit seal stent apposition 5 . Patient aortic mural pathology ≥ 2mm thickness ≥ 50 % circumference proximal fixation site 6 . Patient active , known history , bleed diathesis hypercoagulable condition 7 . Patient contraindication material expose EVAR procedure ( i.e. , Fortevo Endograft HeliFX EndoAnchor System material , contrast agent ) 8 . Patient genetic connective tissue disorder ( e.g. , Marfan 's EhlersDanloe Syndromes )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Aptus Endosystem</keyword>
	<keyword>EndoStaple</keyword>
	<keyword>Endograft</keyword>
	<keyword>Stent Graft</keyword>
	<keyword>Abdominal Aortic Aneurysm</keyword>
	<keyword>Heli-FX</keyword>
	<keyword>EndoAnchor</keyword>
</DOC>